Article Text

Download PDFPDF


Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Goertler M, Blaser T, Krueger S, et al. Cessation of embolic signs after antithrombotic prevention is related to reduced risk of recurrent arterioembolic transient ischaemic attack and stroke. J Neurol Neurosurg Psychiatry 2002;72: 338–42.

Single exponential function was erroneously used for the calculation of figure 2. The correct figure 2 is reproduced below, which shows the predicted probability of recurrent TIA and stroke as calculated from the cumulative underlying hazard and the prognostic index (derived from multivariate regerssion coefficients, mean values of co-variables, and number of embolic signals) by double exponential function.

Shorvon SD, van Rijckevorsel K. A new antiepileptic drug. J Neurol Neurosurg Psychiatry 2002;72:426–9. An error has been noted in rows 1–3 of columns 3 and 4 in table 2. The correct table appears here.

Table 2

Adverse events (%) according to FDA and EMEA standards.

Linked Articles

  • Editorial
    S D Shorvon K van Rijckevorsel